| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.09 | 0.07 |